An essay on protected research transparency will defend this position: The institution should require maximum feasible transparency through preregistration, documented methods, and protected data access where public release is unsafe. The supplied perspectives state: Perspective 1: Detailed methods and accessible data let other researchers test results and identify hidden errors. Perspective 2: Participant privacy and legitimate intellectual-property limits can make unrestricted public release irresponsible. Perspective 3: Controlled repositories, preregistration, and independent verification can disclose more than a simple claim of confidentiality. The governing issue is: How should a research institution promote reproducibility when studies involve sensitive data or commercial methods? Which proposed paragraph most clearly derives a fresh conclusion from compatible insights in the perspectives?